MiMedx Group Inc

MDXG has triggered a bullish pivot above the 9EMA and 20EMA as they rise through the 50 SMA in oversold context, with an active Lockout Rally signaling forced participation and structural repair. Short-term timing conditions favor acting now, and medium-term mean-reversion permission supports a bullish bias into this recovery. The long-term downtrend remains intact, so engagements should be tactical.

• ↑Holds $142M cash, preserving liquidity for buybacks and R&D.
• ↑Authorized $100M buyback, signaling management’s confidence in valuation.
• ↓Q1 revenue plunged 33% YoY to $59M, led by 60% wound care decline.